Amy Spizuoco, DO, FAOCD

home / authors / amy-spizuoco-do-faocd

Amy Spizuoco, DO, FAOCD, is the president of the American Osteopathic College of Dermatology and is an associate clinical instructor in the department of dermatology at The Icahn School of Medicine at Mount Sinai in New York.

Articles

Getting JAK’d With Amy Spizuoco, DO, FAOCD

Getting JAK’d With Amy Spizuoco, DO, FAOCD

Amy Spizuoco, DO, FAOCD;Heidi Anne Duerr, MPH
June 6th 2024

The JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.

Amy Spizuoco, DO, FAOCD: Addressing STDs and Utilizing Dermatopathology With Care in Diverse Patient Populations

Amy Spizuoco, DO, FAOCD: Addressing STDs and Utilizing Dermatopathology With Care in Diverse Patient Populations

Emma Andrus, Associate Editor;Amy Spizuoco, DO, FAOCD
March 27th 2024

Spizuoco shares pearls from her sessions, "Infectious Diseases: The Story Behind STDs," and "Everything You Need to Know About Dermatopathology and the Dermatopathologist," from the Diversity in Dermatology conference.

Editorial Advisory Board Insights for Eczema Awareness Month: Amy Spizuoco, DO, FAOCD

Editorial Advisory Board Insights for Eczema Awareness Month: Amy Spizuoco, DO, FAOCD

Emma Andrus, Associate Editor;Amy Spizuoco, DO, FAOCD
October 7th 2023

Amy Spizuoco, DO, FAOCD, shares her atopic dermatitis insights.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria
Published: April 18th 2025 | Updated: April 22nd 2025
FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria
POLL: Have Your Patients Asked About Cabtreo for Acne?
Published: December 4th 2023 | Updated: April 22nd 2025
POLL: Have Your Patients Asked About Cabtreo for Acne?
POLL: What Percent of Those With Hyperhidrosis Have Discussed Their Sweating With a Health Care Professional?
Published: November 24th 2023 | Updated: April 22nd 2025
POLL: What Percent of Those With Hyperhidrosis Have Discussed Their Sweating With a Health Care Professional?
Exploring the 2025 Revolutionizing Atopic Dermatitis (RAD) Annual Meeting Agenda
Published: April 2nd 2025 | Updated: April 22nd 2025
Exploring the 2025 Revolutionizing Atopic Dermatitis (RAD) Annual Meeting Agenda
Reviewing Complex Cases: Topicals for Pediatric AD
Published: February 25th 2025 | Updated: April 22nd 2025
Reviewing Complex Cases: Topicals for Pediatric AD
© 2025 MJH Life Sciences

All rights reserved.